Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on April 29, 2025
Olon Group 在法国完成两项战略性任命，进一步巩固其在生物生产领域的领先地位
GlobeNewswire
·
April 29, 2025
米兰, April 29, 2025 (GLOBE NEWSWIRE) -- 全球领先的制药合同研发生产组织 (CDMO) Olon Group 宣布任命 Jérôme Bédier 为其法国子公司的首席执行官，同时任命 Andrea Conforto 担任旗下专注于生物制剂 CDMO 服务的业务部门——Olon Biotech CDMO 事业部的市场和销售副总裁。 上述任命进一步巩固了 Olon 在抗体药物偶联物 (ADC)、高活性原料药 (HPAPI) 及微生物生物生产领域拓展能力的战略布局。 ADC、 …
Olon Group 在法國的兩項戰略任命加強了其在生物製藥領域的領導地位
GlobeNewswire
·
April 29, 2025
米蘭, April 29, 2025 (GLOBE NEWSWIRE) -- 全球領先的藥物合同訂製研發和生產組織 (CDMO) 公司 Olon Group 宣布任命 Jérôme Bédier 為其法國實體的行政總裁，並任命 Andrea Conforto 為 Olon 生物技術部門的 CDMO 市場及銷售副總裁 (M…
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
GlobeNewswire
·
April 29, 2025
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene …
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
GlobeNewswire
·
April 29, 2025
– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer – – TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery to baseline activities and overall …
Repligen Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 29, 2025
Revenue of $169 million, year-over-year increase of 10% as reported and 14% organic non-COVID growth Orders increased sequentially and high-teens year-over-year Adjusted operating income increased 72% year-over-year Reiterates 2025 full year organic …
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
GlobeNewswire
·
April 29, 2025
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter …
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
GlobeNewswire
·
April 29, 2025
twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- …
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
GlobeNewswire
·
April 29, 2025
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation OXFORD, UK and CLEVELAND, Ohio, US, 29 April 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and …
Dianthus Therapeutics to Participate in Two Upcoming Investor Events
GlobeNewswire
·
April 29, 2025
NEW YORK and WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference
GlobeNewswire
·
April 29, 2025
MENLO PARK, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including …
Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States
GlobeNewswire
·
April 29, 2025
CLN-978 is the first and only development-stage CD19 T cell engager to receive U.S. FDA IND clearance in autoimmune diseases Sjögren’s disease represents the third indication under development for CLN-978, and is a disease with high unmet need and no …
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
·
April 29, 2025
BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific …
Skye Bioscience to Participate in May Investment and Medical Conferences
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will …
Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 29, 2025
Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 Q1 2025 revenue exceeds operating expenses excluding non-cash charges Conference call today at 9:00 a. …
Ambow Launches HybriU Conferencing: A Next-Gen Platform for Smart, Seamless Phygital (Physical + Digital) Collaboration
GlobeNewswire
·
April 29, 2025
Cupertino, Calif, April 29, 2025 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. (NYSE American: AMBO) (“Ambow” or the “Company”), a leading global EdTech and AI-powered solutions provider, today announced the official launch of HybriU Conferencing, a …
Comment l’IA peut impacter l’industrie des télécoms
GlobeNewswire
·
April 29, 2025
Une chose est désormais évidente, l’intelligence artificielle est aujourd’hui une technologie de rupture qui amène l’ensemble des secteurs d’activités et tous les métiers à évoluer et à intégrer de nouvelles possibilités. Dans ce contexte, le secteur des …
Behind DHgate’s U.S. #2 Milestone: SendCloud Powers Email Engagement as Aurora Mobile & EngageLab Drive Ecosystem Growth
GlobeNewswire
·
April 29, 2025
SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- EngageLab’s parent company, Aurora Mobile (NASDAQ: JG), is proud to announce its subsidiary, SendCloud, provided seamless customer communication for DHgate during its recent unprecedented user surge in the U.S. …
ESET B2B solutions now available on the Microsoft Azure Marketplace
GlobeNewswire
·
April 29, 2025
BRATISLAVA, Slovakia, April 29, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity solutions, today announced the availability of ESET PROTECT solutions in the Microsoft Azure Marketplace, an online store providing applications and services …
Eric McFarland to Serve as NewHydrogen Chief Technology Officer
GlobeNewswire
·
April 29, 2025
Veteran energy expert to lead technical development and commercialization of the Company’s green hydrogen technology SANTA CLARITA, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB:NEWH), the developer of ThermoLoop™, a breakthrough …
Gesamtjahresergebnisse für das am 31. Dezember 2024 endende Jahr
GlobeNewswire
·
April 29, 2025
Ein Jahr des Wandels nach der erfolgreichen Einführung von AGAMREE® Pratteln, Schweiz, 29. April 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt heute die Ergebnisse für das am 31. Dezember 2024 abgeschlossene Geschäftsjahr bekannt. Dario Eklund, CEO von …